000 01338 a2200385 4500
005 20250513095836.0
264 0 _c19961017
008 199610s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm960189i
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHedberg, M H
245 0 0 _a11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cAug 1996
300 _a3503-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDopamine Agonists
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Dopamine D2
_xmetabolism
650 0 4 _aReceptors, Serotonin
_xmetabolism
650 0 4 _aSerotonin Receptor Agonists
_xchemical synthesis
650 0 4 _aStructure-Activity Relationship
700 1 _aLinnanen, T
700 1 _aJansen, J M
700 1 _aNordvall, G
700 1 _aHjorth, S
700 1 _aUnelius, L
700 1 _aJohansson, A M
773 0 _tJournal of medicinal chemistry
_gvol. 39
_gno. 18
_gp. 3503-13
856 4 0 _uhttps://doi.org/10.1021/jm960189i
_zAvailable from publisher's website
999 _c8781177
_d8781177